La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders

* Reuters is not responsible for the content in this press release.

Mon Nov 9, 2009 6:58pm EST

SAN DIEGO--(Business Wire)--
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company") today announced
that its Special Meeting of Stockholders, which was originally convened on
October 30, 2009 and reconvened on November 6, 2009, was adjourned to November
13, 2009 at 11:00 a.m., local time, at 4370 La Jolla Village Drive, Suite 800,
San Diego, California. As described in the Proxy Statement distributed to
stockholders on or about October 7, 2009, the stockholders of the Company are
being asked to vote upon a proposal to approve the liquidation and dissolution
of the Company pursuant to a plan of liquidation and dissolution. Approximately
ninety-three percent (93%) of the Company`s stockholders failed to return their
proxy cards or otherwise indicate their votes with respect to this proposal
prior to the start of the stockholders' meeting. To pass, this proposal must be
approved by holders of at least a majority of the Company`s outstanding voting
shares, and as a result, abstentions and broker non-votes have the same effect
as votes against the proposal. 

Stockholders who have not voted on the proposals described in the Proxy
Statement are encouraged to do so promptly. For stockholders who have already
voted on the proposals, no additional action is necessary if you do not wish to
change your vote. Proxies may be submitted or revoked at any time prior to the
reconvening of the adjourned meeting on November 13, 2009. For assistance in
voting your shares, please contact MacKenzie Partners, Inc., at (800) 322-2885
or call collect at (212) 929-5500. 

Stockholders are urged to read the Proxy Statement, which contains important
information about the stockholders` meeting and the proposals to be voted upon
and it should be read carefully before any decision is made with respect to the
matters to be voted upon.

La Jolla Pharmaceutical Company
Gail A. Sloan
Vice President of Finance and Secretary
858-452-6600
gail.sloan@ljpc.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.